{"gene":"CLCN4","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":2005,"finding":"ClC-4 functions as a secondary active Cl-/H+ antiporter (not a classical Cl- channel), transporting protons across the membrane coupled to chloride flux. Mutation of the pore glutamate E211A abolished H+ transport but not Cl- transport, identifying this residue as essential for proton coupling.","method":"Extracellular pH measurements near cell surface during heterologous expression; pore glutamate mutagenesis (E211A) in Xenopus oocytes","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro electrophysiology with active-site mutagenesis, widely replicated across subsequent studies","pmids":["16034421"],"is_preprint":false},{"year":1999,"finding":"ClC-4 directly mediates strongly outwardly rectifying anion currents (NO3- > Cl- > Br- > I-) when expressed in Xenopus oocytes and HEK293 cells. Mutation E224A in ClC-4 alters voltage dependence and ion selectivity, confirming the protein directly forms the conduction pathway.","method":"Heterologous expression in Xenopus oocytes and HEK293 cells; patch-clamp electrophysiology; point mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with mutagenesis in two heterologous expression systems","pmids":["9873029"],"is_preprint":false},{"year":2003,"finding":"ClC-4 is expressed in endosomal membranes of proximal tubule and cultured epithelial cells; antisense-mediated knockdown of ClC-4 acidified endosomal pH and altered transferrin trafficking. ClC-4 and ClC-5 can be co-immunoprecipitated, suggesting they partially function as a channel complex in endosomes.","method":"Confocal microscopy; antisense cDNA knockdown; endosomal pH measurement; transferrin trafficking assay; co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — multiple orthogonal methods (antisense KD, pH measurement, trafficking assay, co-IP) in a single lab","pmids":["12746443"],"is_preprint":false},{"year":2003,"finding":"Human ClC-4 channels show voltage-dependent unitary current conductance (~0.10 pA at +140 mV) responsible for macroscopic outward rectification; conductivity and permeability sequences increase for anions with lower dehydration energies, defining unique pore properties distinct from other CLC isoforms.","method":"Whole-cell patch-clamp recordings; variance analysis; ion substitution experiments in HEK293/tsA201 cells","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — rigorous single-channel and variance analysis with multiple ion substitutions, single lab","pmids":["12668439"],"is_preprint":false},{"year":2002,"finding":"Recombinant human ClC-4 encodes a small-conductance (~3 pS), nucleotide-dependent (ATP > ATPγS >> AMP-PNP), Ca2+-independent, outwardly rectifying chloride channel inhibited by extracellular acidification. ATP hydrolysis is required for full channel activity.","method":"Whole-cell and single-channel patch-clamp in three mammalian cell lines; nucleotide substitution experiments; pH manipulation","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — single-channel reconstitution with pharmacological dissection in multiple cell lines, single lab","pmids":["11882671"],"is_preprint":false},{"year":2001,"finding":"ClC-4 co-localizes with CFTR at the brush border membrane of intestinal epithelial cells and with endosomal markers EEA1 and transferrin; antisense knockdown of ClC-4 reduced endogenous chloride currents by 50%, demonstrating functional expression on the epithelial cell surface.","method":"Confocal and electron microscopy; antisense cDNA knockdown; patch-clamp electrophysiology in Caco-2 cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — localization confirmed by two microscopy methods; functional consequence established by antisense KD with electrophysiology, single lab","pmids":["11675385"],"is_preprint":false},{"year":2004,"finding":"ClC-4 promotes copper incorporation into ceruloplasmin; overexpression of ClC-4 doubled copper incorporation while identical overexpression of ClC-3 had no effect. ClC-4 co-localizes with the Wilson's disease protein ATP7B in intracellular vesicles and physically associates with it by co-immunoprecipitation.","method":"Co-transfection/overexpression; gel electrophoresis and immunoblotting for holo/apoCeruloplasmin; co-immunoprecipitation; colocalization by microscopy","journal":"Gastroenterology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — functional overexpression assay with isoform specificity control plus co-IP for physical interaction, single lab","pmids":["15057754"],"is_preprint":false},{"year":2006,"finding":"Human ClC-4 localizes to the endoplasmic reticulum (ER) when expressed in HEK293 cells and skeletal muscle fibers; residues 14–63 at the N-terminus constitute a novel ER-targeting motif that is both necessary and sufficient for ER localization. Endogenous ClC-4 was identified in ER/SR membrane fractions from mouse brain.","method":"Heterologous expression in HEK293 cells and muscle fibers; confocal microscopy; subcellular fractionation; N-terminal truncations and chimeric constructs","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — localization confirmed by fractionation of endogenous protein and functional dissection with truncation/chimera mutagenesis","pmids":["17023393"],"is_preprint":false},{"year":2008,"finding":"Zn2+ inhibits human ClC-4 currents with ~50 µM apparent affinity via an extracellular binding site; mutagenesis identified three consecutive histidine residues in an extracellular loop as the Zn2+ binding site. Manipulations altering transport properties (permeant ion changes, gating glutamate mutation) dramatically affect Zn2+ inhibition, implicating this loop region in the transport mechanism.","method":"Two-electrode voltage-clamp in Xenopus oocytes; point mutagenesis of candidate residues; ion substitution experiments","journal":"Biophysical journal","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — systematic mutagenesis of nine candidate residues with electrophysiological readout, single lab","pmids":["18658230"],"is_preprint":false},{"year":2009,"finding":"ClC-4-null fibroblasts show alkaline endosomal pH and reduced transferrin receptor-mediated uptake despite increased surface Tfn receptor expression; the uptake defect is rescued by the iron chelator desferrioxamine, indicating ClC-4 is specifically required for endosomal acidification that drives iron dissociation from transferrin. ClC-4 depletion had no effect on EGFR lysosomal trafficking, demonstrating specificity for recycling endosomes.","method":"Primary fibroblasts from Clcn4 knockout mice; endosomal pH measurement; transferrin uptake assay; EGFR trafficking assay; iron chelator rescue experiment","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout model with multiple orthogonal functional readouts and pharmacological rescue, replicated across ClC-4 studies","pmids":["19339555"],"is_preprint":false},{"year":2017,"finding":"ClC-4 is predominantly monomeric and has weaker homodimerization than ClC-3; co-expression with ClC-3 splice variants (ClC-3a/b or ClC-3c) redirects ClC-4 from ER retention to late endosome/lysosomes or recycling endosomes, respectively. In Clcn3−/− astrocytes, ClC-4 is retained in the ER, confirming ClC-3 is required for ClC-4 endosomal trafficking.","method":"Heterologous expression in HEK293T cells and cultured astrocytes; confocal microscopy; high-resolution clear native gel electrophoresis; Clcn3 knockout cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout validation plus biochemical oligomerization analysis and localization in multiple cell types","pmids":["28972156"],"is_preprint":false},{"year":2022,"finding":"Electrophysiological analysis of 59 CLCN4 missense variants in Xenopus oocytes revealed two mechanistic classes: 25% (15/59) show loss-of-function via a positive shift in voltage-dependent activation, while 9 variants cause toxic gain-of-function via a disrupted gate permitting inward transport at negative voltages.","method":"Two-electrode voltage-clamp in Xenopus laevis oocytes; extended voltage and pH range protocols; systematic variant analysis","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 1 / Strong — large-scale systematic electrophysiological characterization of disease variants with mechanistic classification","pmids":["36385166"],"is_preprint":false},{"year":2022,"finding":"Disease-associated CLCN4 variants produce a spectrum of functional consequences including gain/loss of function, impaired heterodimerization with ClC-3, and subtle transport impairments; even slight functional changes to endosomal Cl-/H+ exchange activity can cause neurological symptoms.","method":"Heterologous expression in mammalian cells; Western blot; confocal imaging; whole-cell patch-clamp electrophysiology; biochemical heterodimerization assays","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods in a single lab characterizing 12 disease variants","pmids":["35721313"],"is_preprint":false},{"year":2024,"finding":"TMEM9B physically interacts with ClC-4 (and ClC-3) and dramatically reduces their transporter activity when co-expressed. FLIM-FRET measurements confirmed direct interaction between TMEM9B and ClC-4, identifying TMEM9B as the first accessory subunit regulator of ClC-4.","method":"Two-electrode voltage-clamp in Xenopus oocytes; whole-cell patch-clamp in HEK cells; FLIM-FRET (fluorescence lifetime microscopy-based FRET)","journal":"Life (Basel, Switzerland)","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct interaction confirmed by FLIM-FRET with functional electrophysiological readout in two expression systems; isoform specificity controls included","pmids":["39202776"],"is_preprint":false},{"year":2024,"finding":"The CLCN4 variant p.(Gly342Arg) significantly impairs ClC-4 heterodimerization with ClC-3 and suppresses anion currents; p.(Ile549Leu) and p.(Asp89Asn) shift voltage dependency of activation by 20 mV (hyperpolarizing), with p.(Asp89Asn) producing gain-of-transport function.","method":"Patch-clamp electrophysiology; protein biochemistry; confocal fluorescence microscopy in mammalian cells","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (electrophysiology, biochemistry, imaging) applied to three disease variants in a single lab","pmids":["38578438"],"is_preprint":false},{"year":2025,"finding":"Three CLCN4 disease variants exhibit dominant-negative effects within ClC-3/ClC-4 heterodimers, suppressing the transport activity of co-expressed wild-type ClC-3, providing the first evidence that CLCN4 variants can act dominantly through the heterodimer complex.","method":"Two-electrode voltage-clamp in Xenopus laevis oocytes; whole-cell patch-clamp in mammalian cells co-expressing ClC-3 and ClC-4 via bicistronic IRES construct","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — electrophysiological reconstitution in two expression systems, single lab, novel mechanistic finding","pmids":["41439993"],"is_preprint":false},{"year":2025,"finding":"CLCN4 variants reduce excitatory neuron numbers in brain organoids due to early-stage cell death, associated with altered endo-lysosomal dynamics and disrupted autophagic flux; lncRNA MEG3 is downregulated in CLCN4-variant neurons and restoring MEG3 expression rescues cellular defects and improves neuronal survival.","method":"Brain organoids and neuronal cell systems from CLCN4 patient-relevant variants; transcriptomic profiling; autophagic flux assays; MEG3 rescue experiments","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, single lab, novel model system without independent replication; methods not fully detailed in abstract","pmids":["bio_10.1101_2025.07.16.665078"],"is_preprint":true},{"year":2025,"finding":"Knockdown of CLCN4 in KdVS hiPSC-derived neurons restored network burst rate to control levels, confirming a causal relationship between elevated CLCN4 expression and reduced neuronal network burst rate.","method":"CLCN4 knockdown in hiPSC-derived neurons; microelectrode array (MEA) recordings; MEA-seq integrative framework","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, single lab, loss-of-function with defined electrophysiological phenotype but no pathway mechanism established","pmids":["bio_10.1101_2024.08.29.610281"],"is_preprint":true},{"year":2021,"finding":"All evaluated CLCN4 variants in patients with epilepsy resulted in loss-of-function with reduced ClC-4 currents as assessed by electrophysiology; frameshift/intragenic deletion/inherited variants were associated with milder phenotypes while missense/de novo variants led to more severe phenotypes.","method":"Western blot; immunofluorescence; electrophysiological measurements in heterologous expression; clinical variant classification","journal":"Epilepsia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiological loss-of-function demonstrated for multiple variants with supporting biochemical data, single lab","pmids":["33951195"],"is_preprint":false}],"current_model":"ClC-4 (CLCN4) is a secondary active Cl-/H+ antiporter (2Cl-:1H+ exchange) localized primarily to endosomal membranes, where it acidifies endosomal lumen and supports transferrin receptor recycling and copper incorporation into ceruloplasmin; its ER-to-endosome trafficking depends on heterodimerization with ClC-3 (mediated by an N-terminal ER-retention motif, residues 14–63, overridden by ClC-3 interaction), its transport activity is regulated by the accessory protein TMEM9B, and disease-causing variants produce either loss-of-function (voltage-activation shift), gain-of-function (inward transport at negative voltages), or dominant-negative effects within ClC-3/ClC-4 heterodimers, all converging on disrupted endo-lysosomal ion homeostasis and neuronal dysfunction."},"narrative":{"mechanistic_narrative":"CLCN4 encodes ClC-4, a secondary active Cl-/H+ antiporter that drives endosomal acidification and supports recycling-endosome function [PMID:16034421, PMID:19339555]. Originally characterized as a strongly outwardly rectifying anion conductance in heterologous systems [PMID:9873029, PMID:12668439], ClC-4 was redefined as a 2Cl-:1H+ exchanger in which the pore glutamate (E211) couples proton movement to chloride flux, since its mutation abolishes H+ transport while sparing Cl- transport [PMID:16034421]. In endosomal membranes ClC-4 acidifies the endosomal lumen to permit iron dissociation from transferrin and proper transferrin-receptor recycling, a function established in Clcn4-null fibroblasts that show alkaline endosomes and a desferrioxamine-rescuable uptake defect specific to recycling endosomes rather than lysosomal EGFR trafficking [PMID:19339555]. ClC-4 additionally promotes copper incorporation into ceruloplasmin in association with the Wilson's-disease protein ATP7B [PMID:15057754]. ClC-4 is largely monomeric with an N-terminal ER-retention motif (residues 14-63) that confines it to the ER until heterodimerization with ClC-3 redirects it to recycling or late endosomes/lysosomes [PMID:17023393, PMID:28972156]; its transport activity is further suppressed by the accessory protein TMEM9B [PMID:39202776]. Disease-causing CLCN4 variants act through distinct mechanisms — loss-of-function via positive shifts in voltage-dependent activation, toxic gain-of-function permitting inward transport at negative voltages, impaired ClC-3 heterodimerization, and dominant-negative suppression of wild-type ClC-3 within heterodimers — all converging on disrupted endo-lysosomal ion homeostasis and neuronal dysfunction [PMID:36385166, PMID:41439993, PMID:33951195].","teleology":[{"year":1999,"claim":"Established that ClC-4 itself forms the anion conduction pathway rather than acting as a regulatory subunit, by showing the protein directly mediates outwardly rectifying anion currents whose selectivity is altered by pore mutation.","evidence":"Heterologous expression and patch-clamp with E224A mutagenesis in Xenopus oocytes and HEK293 cells","pmids":["9873029"],"confidence":"High","gaps":["Did not resolve whether ClC-4 is a channel or transporter","No physiological substrate or localization defined"]},{"year":2002,"claim":"Defined the biophysical fingerprint of ClC-4 as a small-conductance, nucleotide- and pH-sensitive outwardly rectifying conductance, characterizing its regulatory dependencies.","evidence":"Whole-cell and single-channel patch-clamp with nucleotide substitution in three mammalian cell lines","pmids":["11882671"],"confidence":"High","gaps":["ATP requirement mechanism unresolved","Interpreted as a channel before transporter model emerged"]},{"year":2003,"claim":"Linked ClC-4 to endosomal physiology by localizing it to endosomes and showing its depletion alters endosomal pH and transferrin trafficking, and reported co-IP with ClC-5.","evidence":"Confocal microscopy, antisense knockdown, endosomal pH and transferrin assays, and co-immunoprecipitation","pmids":["12746443"],"confidence":"Medium","gaps":["ClC-5 interaction not reciprocally validated","Single lab; direction of pH change vs transport mechanism unclear at the time"]},{"year":2005,"claim":"Reclassified ClC-4 from a classical chloride channel to a secondary active Cl-/H+ antiporter and pinpointed the pore glutamate E211 as essential for proton coupling.","evidence":"Surface pH measurements during heterologous expression with E211A pore-glutamate mutagenesis in Xenopus oocytes","pmids":["16034421"],"confidence":"High","gaps":["Exact stoichiometry not defined in this finding","Structural basis of coupling not resolved"]},{"year":2006,"claim":"Identified an N-terminal ER-targeting motif (residues 14-63) that explains why ClC-4 is retained in the ER, establishing a trafficking determinant.","evidence":"Heterologous expression, subcellular fractionation of endogenous protein, and N-terminal truncation/chimera constructs","pmids":["17023393"],"confidence":"High","gaps":["How the motif is overridden for endosomal delivery not yet known","Partner mediating exit not identified"]},{"year":2009,"claim":"Provided genetic proof that ClC-4 is required for endosomal acidification driving iron release from transferrin, with specificity for recycling endosomes.","evidence":"Clcn4 knockout mouse fibroblasts with endosomal pH, transferrin uptake, EGFR trafficking assays, and iron-chelator rescue","pmids":["19339555"],"confidence":"High","gaps":["Did not address neuronal phenotypes","Trafficking route to endosomes not mechanistically explained"]},{"year":2017,"claim":"Resolved the trafficking determinant question by showing ClC-4 is monomeric and depends on heterodimerization with ClC-3 to escape the ER and reach endosomal compartments.","evidence":"Heterologous co-expression, native gel electrophoresis, and Clcn3 knockout astrocytes","pmids":["28972156"],"confidence":"High","gaps":["Structural interface of the heterodimer not defined","Relative in vivo abundance of homo- vs heterodimers unknown"]},{"year":2022,"claim":"Systematically classified disease variants into mechanistic categories, distinguishing loss-of-function from toxic gain-of-function, framing genotype-mechanism relationships for CLCN4 disease.","evidence":"Two-electrode voltage-clamp of 59 missense variants in Xenopus oocytes; complementary characterization of additional variants in mammalian cells","pmids":["36385166","35721313"],"confidence":"High","gaps":["Cellular consequences of each class not directly tested","Link to specific clinical severity incompletely mapped"]},{"year":2024,"claim":"Identified TMEM9B as the first accessory subunit regulator of ClC-4 that directly binds and suppresses its transport activity.","evidence":"Two-electrode and whole-cell patch-clamp with FLIM-FRET interaction measurement in oocytes and HEK cells","pmids":["39202776"],"confidence":"High","gaps":["Physiological context of TMEM9B regulation in vivo unknown","Mechanism of activity suppression not resolved"]},{"year":2025,"claim":"Demonstrated that CLCN4 variants can act dominant-negatively by suppressing wild-type ClC-3 within heterodimers, explaining dominant disease inheritance.","evidence":"Voltage-clamp reconstitution of co-expressed ClC-3/ClC-4 via bicistronic constructs in oocytes and mammalian cells","pmids":["41439993"],"confidence":"Medium","gaps":["Single lab","Endogenous-level dominant effect not confirmed in patient cells"]},{"year":2025,"claim":"Began connecting CLCN4 dysfunction to neuronal-level phenotypes, linking variants to excitatory neuron loss, autophagic disruption, and altered network activity.","evidence":"Brain organoids and hiPSC-derived neurons with transcriptomics, autophagy assays, MEG3 rescue, and microelectrode array recordings (both preprints)","pmids":["bio_10.1101_2025.07.16.665078","bio_10.1101_2024.08.29.610281"],"confidence":"Low","gaps":["Preprints without independent replication","Mechanistic link from ion transport to MEG3/autophagy not established","Direction of expression change (loss vs gain) varies between models"]},{"year":null,"claim":"How endosomal Cl-/H+ exchange by ClC-4 is mechanistically translated into the cell-death, autophagy, and network-activity defects underlying neurodevelopmental disease remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of the ClC-3/ClC-4 heterodimer","Causal chain from ion homeostasis to neuronal phenotype unestablished","In vivo role of TMEM9B regulation unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,9]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[2,5,9,10]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[7,10]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[10]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,9]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2,9]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[6,9]}],"complexes":["ClC-3/ClC-4 heterodimer"],"partners":["CLCN3","CLCN5","ATP7B","TMEM9B","CFTR"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P51793","full_name":"H(+)/Cl(-) exchange transporter 4","aliases":["Chloride channel protein 4","ClC-4","Chloride transporter ClC-4"],"length_aa":760,"mass_kda":84.9,"function":"Strongly outwardly rectifying, electrogenic H(+)/Cl(-)exchanger which mediates the exchange of chloride ions against protons (PubMed:18063579, PubMed:23647072, PubMed:25644381, PubMed:27550844, PubMed:28972156). The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons (PubMed:29845874). The presence of conserved gating glutamate residues is typical for family members that function as antiporters (PubMed:29845874)","subcellular_location":"Early endosome membrane; Late endosome membrane; Endoplasmic reticulum membrane; Lysosome membrane; Recycling endosome membrane","url":"https://www.uniprot.org/uniprotkb/P51793/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CLCN4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CLCN4","total_profiled":1310},"omim":[{"mim_id":"615400","title":"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY; EPEO5","url":"https://www.omim.org/entry/615400"},{"mim_id":"600580","title":"CHLORIDE CHANNEL 3; CLCN3","url":"https://www.omim.org/entry/600580"},{"mim_id":"302910","title":"CHLORIDE CHANNEL 4; CLCN4","url":"https://www.omim.org/entry/302910"},{"mim_id":"300552","title":"MIDLINE 1; MID1","url":"https://www.omim.org/entry/300552"},{"mim_id":"300114","title":"RAYNAUD-CLAES SYNDROME; MRXSRC","url":"https://www.omim.org/entry/300114"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":27.3},{"tissue":"retina","ntpm":35.1},{"tissue":"skeletal muscle","ntpm":41.9},{"tissue":"tongue","ntpm":32.0}],"url":"https://www.proteinatlas.org/search/CLCN4"},"hgnc":{"alias_symbol":["CLC4","ClC-4"],"prev_symbol":[]},"alphafold":{"accession":"P51793","domains":[{"cath_id":"1.10.3080.10","chopping":"80-307","consensus_level":"medium","plddt":89.2624,"start":80,"end":307},{"cath_id":"1.10.3080.10","chopping":"333-368_429-578","consensus_level":"high","plddt":89.8486,"start":333,"end":578},{"cath_id":"3.10.580.20","chopping":"595-749","consensus_level":"high","plddt":86.6388,"start":595,"end":749}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51793","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51793-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51793-F1-predicted_aligned_error_v6.png","plddt_mean":84.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CLCN4","jax_strain_url":"https://www.jax.org/strain/search?query=CLCN4"},"sequence":{"accession":"P51793","fasta_url":"https://rest.uniprot.org/uniprotkb/P51793.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51793/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51793"}},"corpus_meta":[{"pmid":"16034421","id":"PMC_16034421","title":"Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16034421","citation_count":377,"is_preprint":false},{"pmid":"9873029","id":"PMC_9873029","title":"Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9873029","citation_count":209,"is_preprint":false},{"pmid":"12746443","id":"PMC_12746443","title":"The chloride channel ClC-4 contributes to endosomal acidification and trafficking.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12746443","citation_count":85,"is_preprint":false},{"pmid":"7670496","id":"PMC_7670496","title":"Different chromosomal localization of the Clcn4 gene in Mus spretus and C57BL/6J mice.","date":"1995","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7670496","citation_count":72,"is_preprint":false},{"pmid":"27550844","id":"PMC_27550844","title":"De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females.","date":"2016","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27550844","citation_count":57,"is_preprint":false},{"pmid":"12668439","id":"PMC_12668439","title":"Anion permeation in human ClC-4 channels.","date":"2003","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12668439","citation_count":49,"is_preprint":false},{"pmid":"11882671","id":"PMC_11882671","title":"Functional characterization of recombinant human ClC-4 chloride channels in cultured mammalian cells.","date":"2002","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11882671","citation_count":48,"is_preprint":false},{"pmid":"11675385","id":"PMC_11675385","title":"The chloride channel ClC-4 co-localizes with cystic fibrosis transmembrane conductance regulator and may mediate chloride flux across the apical membrane of intestinal epithelia.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11675385","citation_count":47,"is_preprint":false},{"pmid":"19546591","id":"PMC_19546591","title":"Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease.","date":"2009","source":"Nephron. Physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19546591","citation_count":28,"is_preprint":false},{"pmid":"36385166","id":"PMC_36385166","title":"Functional and clinical studies reveal pathophysiological complexity of CLCN4-related neurodevelopmental condition.","date":"2022","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/36385166","citation_count":27,"is_preprint":false},{"pmid":"17023393","id":"PMC_17023393","title":"The human ClC-4 protein, a member of the CLC chloride channel/transporter family, is localized to the endoplasmic reticulum by its N-terminus.","date":"2006","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17023393","citation_count":27,"is_preprint":false},{"pmid":"15057754","id":"PMC_15057754","title":"Involvement of chloride channels in hepatic copper metabolism: ClC-4 promotes copper incorporation into ceruloplasmin.","date":"2004","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/15057754","citation_count":27,"is_preprint":false},{"pmid":"33951195","id":"PMC_33951195","title":"The molecular and phenotypic spectrum of CLCN4-related epilepsy.","date":"2021","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/33951195","citation_count":25,"is_preprint":false},{"pmid":"28972156","id":"PMC_28972156","title":"Preferential association with ClC-3 permits sorting of ClC-4 into endosomal compartments.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28972156","citation_count":24,"is_preprint":false},{"pmid":"19339555","id":"PMC_19339555","title":"An essential role for ClC-4 in transferrin receptor function revealed in studies of fibroblasts derived from Clcn4-null mice.","date":"2009","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/19339555","citation_count":21,"is_preprint":false},{"pmid":"21282478","id":"PMC_21282478","title":"Clcn4-2 genomic structure differs between the X locus in Mus spretus and the autosomal locus in Mus musculus: AT motif enrichment on the X.","date":"2011","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/21282478","citation_count":18,"is_preprint":false},{"pmid":"18658230","id":"PMC_18658230","title":"Insights into the ClC-4 transport mechanism from studies of Zn2+ inhibition.","date":"2008","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/18658230","citation_count":16,"is_preprint":false},{"pmid":"35721313","id":"PMC_35721313","title":"Functional Characterization of CLCN4 Variants Associated With X-Linked Intellectual Disability and Epilepsy.","date":"2022","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35721313","citation_count":13,"is_preprint":false},{"pmid":"34479510","id":"PMC_34479510","title":"Novel CLCN4 variant associated with syndromic X-linked intellectual disability in a Chinese girl: a case report.","date":"2021","source":"BMC pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/34479510","citation_count":12,"is_preprint":false},{"pmid":"39863599","id":"PMC_39863599","title":"Developmental deficits, synapse and dendritic abnormalities in a Clcn4 KO autism mice model: endophenotypic target for ASD.","date":"2025","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/39863599","citation_count":9,"is_preprint":false},{"pmid":"37359369","id":"PMC_37359369","title":"Whole exome sequencing identified five novel variants in CNTN2, CARS2, ARSA, and CLCN4 leading to epilepsy in consanguineous families.","date":"2023","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37359369","citation_count":8,"is_preprint":false},{"pmid":"39202776","id":"PMC_39202776","title":"TMEM9B Regulates Endosomal ClC-3 and ClC-4 Transporters.","date":"2024","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/39202776","citation_count":7,"is_preprint":false},{"pmid":"37789889","id":"PMC_37789889","title":"Novel variants in the CLCN4 gene associated with syndromic X-linked intellectual disability.","date":"2023","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37789889","citation_count":6,"is_preprint":false},{"pmid":"38578438","id":"PMC_38578438","title":"Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy.","date":"2024","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38578438","citation_count":5,"is_preprint":false},{"pmid":"38758281","id":"PMC_38758281","title":"Expanding the genetic and phenotypic relevance of CLCN4 variants in neurodevelopmental condition: 13 new patients.","date":"2024","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/38758281","citation_count":4,"is_preprint":false},{"pmid":"37271660","id":"PMC_37271660","title":"Developmental and epileptic encephalopathy in a young Italian woman with a de novo missense variant in the CLCN4 gene: A case report.","date":"2023","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/37271660","citation_count":2,"is_preprint":false},{"pmid":"37409888","id":"PMC_37409888","title":"Prenatal diagnosis of CLCN4-related neurodevelopmental disorder in fetuses with congenital brain anomalies.","date":"2023","source":"Prenatal diagnosis","url":"https://pubmed.ncbi.nlm.nih.gov/37409888","citation_count":2,"is_preprint":false},{"pmid":"38482266","id":"PMC_38482266","title":"Experience with the Ketogenic Diet in a Boy with CLCN4 Related Neurodevelopmental Disorder.","date":"2024","source":"Balkan journal of medical genetics : BJMG","url":"https://pubmed.ncbi.nlm.nih.gov/38482266","citation_count":2,"is_preprint":false},{"pmid":"37671947","id":"PMC_37671947","title":"Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37671947","citation_count":1,"is_preprint":false},{"pmid":"41439993","id":"PMC_41439993","title":"Dominant Action of CLCN4 Neurodevelopmental Disease Variants in Heteromeric Endosomal ClC-3/ClC-4 Transporters.","date":"2025","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/41439993","citation_count":0,"is_preprint":false},{"pmid":"40800199","id":"PMC_40800199","title":"Clinical features and genetic analysis of epilepsy caused by CLCN4 gene mutation: a case report and literature review.","date":"2025","source":"Translational pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/40800199","citation_count":0,"is_preprint":false},{"pmid":"37730231","id":"PMC_37730231","title":"[Analysis of CLCN4 gene variant in a child with Raynaud-Claes syndrome].","date":"2023","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37730231","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.16.665078","title":"<i>MEG3</i>  Enhances Survival of Developing Human Neurons with  <i>CLCN4</i>  -Linked Autophagy Impairment","date":"2025-07-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.16.665078","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.29.610281","title":"Integrative transcriptomics and electrophysiological profiling of hiPSC-derived neurons identifies novel druggable pathways in Koolen-de Vries Syndrome","date":"2024-08-30","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.29.610281","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19148,"output_tokens":4635,"usd":0.063484,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12728,"output_tokens":3712,"usd":0.07822,"stage2_stop_reason":"end_turn"},"total_usd":0.141704,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"ClC-4 functions as a secondary active Cl-/H+ antiporter (not a classical Cl- channel), transporting protons across the membrane coupled to chloride flux. Mutation of the pore glutamate E211A abolished H+ transport but not Cl- transport, identifying this residue as essential for proton coupling.\",\n      \"method\": \"Extracellular pH measurements near cell surface during heterologous expression; pore glutamate mutagenesis (E211A) in Xenopus oocytes\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro electrophysiology with active-site mutagenesis, widely replicated across subsequent studies\",\n      \"pmids\": [\"16034421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ClC-4 directly mediates strongly outwardly rectifying anion currents (NO3- > Cl- > Br- > I-) when expressed in Xenopus oocytes and HEK293 cells. Mutation E224A in ClC-4 alters voltage dependence and ion selectivity, confirming the protein directly forms the conduction pathway.\",\n      \"method\": \"Heterologous expression in Xenopus oocytes and HEK293 cells; patch-clamp electrophysiology; point mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with mutagenesis in two heterologous expression systems\",\n      \"pmids\": [\"9873029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ClC-4 is expressed in endosomal membranes of proximal tubule and cultured epithelial cells; antisense-mediated knockdown of ClC-4 acidified endosomal pH and altered transferrin trafficking. ClC-4 and ClC-5 can be co-immunoprecipitated, suggesting they partially function as a channel complex in endosomes.\",\n      \"method\": \"Confocal microscopy; antisense cDNA knockdown; endosomal pH measurement; transferrin trafficking assay; co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — multiple orthogonal methods (antisense KD, pH measurement, trafficking assay, co-IP) in a single lab\",\n      \"pmids\": [\"12746443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Human ClC-4 channels show voltage-dependent unitary current conductance (~0.10 pA at +140 mV) responsible for macroscopic outward rectification; conductivity and permeability sequences increase for anions with lower dehydration energies, defining unique pore properties distinct from other CLC isoforms.\",\n      \"method\": \"Whole-cell patch-clamp recordings; variance analysis; ion substitution experiments in HEK293/tsA201 cells\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — rigorous single-channel and variance analysis with multiple ion substitutions, single lab\",\n      \"pmids\": [\"12668439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Recombinant human ClC-4 encodes a small-conductance (~3 pS), nucleotide-dependent (ATP > ATPγS >> AMP-PNP), Ca2+-independent, outwardly rectifying chloride channel inhibited by extracellular acidification. ATP hydrolysis is required for full channel activity.\",\n      \"method\": \"Whole-cell and single-channel patch-clamp in three mammalian cell lines; nucleotide substitution experiments; pH manipulation\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — single-channel reconstitution with pharmacological dissection in multiple cell lines, single lab\",\n      \"pmids\": [\"11882671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"ClC-4 co-localizes with CFTR at the brush border membrane of intestinal epithelial cells and with endosomal markers EEA1 and transferrin; antisense knockdown of ClC-4 reduced endogenous chloride currents by 50%, demonstrating functional expression on the epithelial cell surface.\",\n      \"method\": \"Confocal and electron microscopy; antisense cDNA knockdown; patch-clamp electrophysiology in Caco-2 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — localization confirmed by two microscopy methods; functional consequence established by antisense KD with electrophysiology, single lab\",\n      \"pmids\": [\"11675385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ClC-4 promotes copper incorporation into ceruloplasmin; overexpression of ClC-4 doubled copper incorporation while identical overexpression of ClC-3 had no effect. ClC-4 co-localizes with the Wilson's disease protein ATP7B in intracellular vesicles and physically associates with it by co-immunoprecipitation.\",\n      \"method\": \"Co-transfection/overexpression; gel electrophoresis and immunoblotting for holo/apoCeruloplasmin; co-immunoprecipitation; colocalization by microscopy\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — functional overexpression assay with isoform specificity control plus co-IP for physical interaction, single lab\",\n      \"pmids\": [\"15057754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Human ClC-4 localizes to the endoplasmic reticulum (ER) when expressed in HEK293 cells and skeletal muscle fibers; residues 14–63 at the N-terminus constitute a novel ER-targeting motif that is both necessary and sufficient for ER localization. Endogenous ClC-4 was identified in ER/SR membrane fractions from mouse brain.\",\n      \"method\": \"Heterologous expression in HEK293 cells and muscle fibers; confocal microscopy; subcellular fractionation; N-terminal truncations and chimeric constructs\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — localization confirmed by fractionation of endogenous protein and functional dissection with truncation/chimera mutagenesis\",\n      \"pmids\": [\"17023393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Zn2+ inhibits human ClC-4 currents with ~50 µM apparent affinity via an extracellular binding site; mutagenesis identified three consecutive histidine residues in an extracellular loop as the Zn2+ binding site. Manipulations altering transport properties (permeant ion changes, gating glutamate mutation) dramatically affect Zn2+ inhibition, implicating this loop region in the transport mechanism.\",\n      \"method\": \"Two-electrode voltage-clamp in Xenopus oocytes; point mutagenesis of candidate residues; ion substitution experiments\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — systematic mutagenesis of nine candidate residues with electrophysiological readout, single lab\",\n      \"pmids\": [\"18658230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ClC-4-null fibroblasts show alkaline endosomal pH and reduced transferrin receptor-mediated uptake despite increased surface Tfn receptor expression; the uptake defect is rescued by the iron chelator desferrioxamine, indicating ClC-4 is specifically required for endosomal acidification that drives iron dissociation from transferrin. ClC-4 depletion had no effect on EGFR lysosomal trafficking, demonstrating specificity for recycling endosomes.\",\n      \"method\": \"Primary fibroblasts from Clcn4 knockout mice; endosomal pH measurement; transferrin uptake assay; EGFR trafficking assay; iron chelator rescue experiment\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout model with multiple orthogonal functional readouts and pharmacological rescue, replicated across ClC-4 studies\",\n      \"pmids\": [\"19339555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ClC-4 is predominantly monomeric and has weaker homodimerization than ClC-3; co-expression with ClC-3 splice variants (ClC-3a/b or ClC-3c) redirects ClC-4 from ER retention to late endosome/lysosomes or recycling endosomes, respectively. In Clcn3−/− astrocytes, ClC-4 is retained in the ER, confirming ClC-3 is required for ClC-4 endosomal trafficking.\",\n      \"method\": \"Heterologous expression in HEK293T cells and cultured astrocytes; confocal microscopy; high-resolution clear native gel electrophoresis; Clcn3 knockout cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout validation plus biochemical oligomerization analysis and localization in multiple cell types\",\n      \"pmids\": [\"28972156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Electrophysiological analysis of 59 CLCN4 missense variants in Xenopus oocytes revealed two mechanistic classes: 25% (15/59) show loss-of-function via a positive shift in voltage-dependent activation, while 9 variants cause toxic gain-of-function via a disrupted gate permitting inward transport at negative voltages.\",\n      \"method\": \"Two-electrode voltage-clamp in Xenopus laevis oocytes; extended voltage and pH range protocols; systematic variant analysis\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — large-scale systematic electrophysiological characterization of disease variants with mechanistic classification\",\n      \"pmids\": [\"36385166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Disease-associated CLCN4 variants produce a spectrum of functional consequences including gain/loss of function, impaired heterodimerization with ClC-3, and subtle transport impairments; even slight functional changes to endosomal Cl-/H+ exchange activity can cause neurological symptoms.\",\n      \"method\": \"Heterologous expression in mammalian cells; Western blot; confocal imaging; whole-cell patch-clamp electrophysiology; biochemical heterodimerization assays\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods in a single lab characterizing 12 disease variants\",\n      \"pmids\": [\"35721313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TMEM9B physically interacts with ClC-4 (and ClC-3) and dramatically reduces their transporter activity when co-expressed. FLIM-FRET measurements confirmed direct interaction between TMEM9B and ClC-4, identifying TMEM9B as the first accessory subunit regulator of ClC-4.\",\n      \"method\": \"Two-electrode voltage-clamp in Xenopus oocytes; whole-cell patch-clamp in HEK cells; FLIM-FRET (fluorescence lifetime microscopy-based FRET)\",\n      \"journal\": \"Life (Basel, Switzerland)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct interaction confirmed by FLIM-FRET with functional electrophysiological readout in two expression systems; isoform specificity controls included\",\n      \"pmids\": [\"39202776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The CLCN4 variant p.(Gly342Arg) significantly impairs ClC-4 heterodimerization with ClC-3 and suppresses anion currents; p.(Ile549Leu) and p.(Asp89Asn) shift voltage dependency of activation by 20 mV (hyperpolarizing), with p.(Asp89Asn) producing gain-of-transport function.\",\n      \"method\": \"Patch-clamp electrophysiology; protein biochemistry; confocal fluorescence microscopy in mammalian cells\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (electrophysiology, biochemistry, imaging) applied to three disease variants in a single lab\",\n      \"pmids\": [\"38578438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Three CLCN4 disease variants exhibit dominant-negative effects within ClC-3/ClC-4 heterodimers, suppressing the transport activity of co-expressed wild-type ClC-3, providing the first evidence that CLCN4 variants can act dominantly through the heterodimer complex.\",\n      \"method\": \"Two-electrode voltage-clamp in Xenopus laevis oocytes; whole-cell patch-clamp in mammalian cells co-expressing ClC-3 and ClC-4 via bicistronic IRES construct\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — electrophysiological reconstitution in two expression systems, single lab, novel mechanistic finding\",\n      \"pmids\": [\"41439993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CLCN4 variants reduce excitatory neuron numbers in brain organoids due to early-stage cell death, associated with altered endo-lysosomal dynamics and disrupted autophagic flux; lncRNA MEG3 is downregulated in CLCN4-variant neurons and restoring MEG3 expression rescues cellular defects and improves neuronal survival.\",\n      \"method\": \"Brain organoids and neuronal cell systems from CLCN4 patient-relevant variants; transcriptomic profiling; autophagic flux assays; MEG3 rescue experiments\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, single lab, novel model system without independent replication; methods not fully detailed in abstract\",\n      \"pmids\": [\"bio_10.1101_2025.07.16.665078\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Knockdown of CLCN4 in KdVS hiPSC-derived neurons restored network burst rate to control levels, confirming a causal relationship between elevated CLCN4 expression and reduced neuronal network burst rate.\",\n      \"method\": \"CLCN4 knockdown in hiPSC-derived neurons; microelectrode array (MEA) recordings; MEA-seq integrative framework\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, single lab, loss-of-function with defined electrophysiological phenotype but no pathway mechanism established\",\n      \"pmids\": [\"bio_10.1101_2024.08.29.610281\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"All evaluated CLCN4 variants in patients with epilepsy resulted in loss-of-function with reduced ClC-4 currents as assessed by electrophysiology; frameshift/intragenic deletion/inherited variants were associated with milder phenotypes while missense/de novo variants led to more severe phenotypes.\",\n      \"method\": \"Western blot; immunofluorescence; electrophysiological measurements in heterologous expression; clinical variant classification\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiological loss-of-function demonstrated for multiple variants with supporting biochemical data, single lab\",\n      \"pmids\": [\"33951195\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ClC-4 (CLCN4) is a secondary active Cl-/H+ antiporter (2Cl-:1H+ exchange) localized primarily to endosomal membranes, where it acidifies endosomal lumen and supports transferrin receptor recycling and copper incorporation into ceruloplasmin; its ER-to-endosome trafficking depends on heterodimerization with ClC-3 (mediated by an N-terminal ER-retention motif, residues 14–63, overridden by ClC-3 interaction), its transport activity is regulated by the accessory protein TMEM9B, and disease-causing variants produce either loss-of-function (voltage-activation shift), gain-of-function (inward transport at negative voltages), or dominant-negative effects within ClC-3/ClC-4 heterodimers, all converging on disrupted endo-lysosomal ion homeostasis and neuronal dysfunction.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CLCN4 encodes ClC-4, a secondary active Cl-/H+ antiporter that drives endosomal acidification and supports recycling-endosome function [#0, #9]. Originally characterized as a strongly outwardly rectifying anion conductance in heterologous systems [#1, #3], ClC-4 was redefined as a 2Cl-:1H+ exchanger in which the pore glutamate (E211) couples proton movement to chloride flux, since its mutation abolishes H+ transport while sparing Cl- transport [#0]. In endosomal membranes ClC-4 acidifies the endosomal lumen to permit iron dissociation from transferrin and proper transferrin-receptor recycling, a function established in Clcn4-null fibroblasts that show alkaline endosomes and a desferrioxamine-rescuable uptake defect specific to recycling endosomes rather than lysosomal EGFR trafficking [#9]. ClC-4 additionally promotes copper incorporation into ceruloplasmin in association with the Wilson's-disease protein ATP7B [#6]. ClC-4 is largely monomeric with an N-terminal ER-retention motif (residues 14-63) that confines it to the ER until heterodimerization with ClC-3 redirects it to recycling or late endosomes/lysosomes [#7, #10]; its transport activity is further suppressed by the accessory protein TMEM9B [#13]. Disease-causing CLCN4 variants act through distinct mechanisms — loss-of-function via positive shifts in voltage-dependent activation, toxic gain-of-function permitting inward transport at negative voltages, impaired ClC-3 heterodimerization, and dominant-negative suppression of wild-type ClC-3 within heterodimers — all converging on disrupted endo-lysosomal ion homeostasis and neuronal dysfunction [#11, #15, #18].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established that ClC-4 itself forms the anion conduction pathway rather than acting as a regulatory subunit, by showing the protein directly mediates outwardly rectifying anion currents whose selectivity is altered by pore mutation.\",\n      \"evidence\": \"Heterologous expression and patch-clamp with E224A mutagenesis in Xenopus oocytes and HEK293 cells\",\n      \"pmids\": [\"9873029\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve whether ClC-4 is a channel or transporter\", \"No physiological substrate or localization defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defined the biophysical fingerprint of ClC-4 as a small-conductance, nucleotide- and pH-sensitive outwardly rectifying conductance, characterizing its regulatory dependencies.\",\n      \"evidence\": \"Whole-cell and single-channel patch-clamp with nucleotide substitution in three mammalian cell lines\",\n      \"pmids\": [\"11882671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ATP requirement mechanism unresolved\", \"Interpreted as a channel before transporter model emerged\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Linked ClC-4 to endosomal physiology by localizing it to endosomes and showing its depletion alters endosomal pH and transferrin trafficking, and reported co-IP with ClC-5.\",\n      \"evidence\": \"Confocal microscopy, antisense knockdown, endosomal pH and transferrin assays, and co-immunoprecipitation\",\n      \"pmids\": [\"12746443\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ClC-5 interaction not reciprocally validated\", \"Single lab; direction of pH change vs transport mechanism unclear at the time\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Reclassified ClC-4 from a classical chloride channel to a secondary active Cl-/H+ antiporter and pinpointed the pore glutamate E211 as essential for proton coupling.\",\n      \"evidence\": \"Surface pH measurements during heterologous expression with E211A pore-glutamate mutagenesis in Xenopus oocytes\",\n      \"pmids\": [\"16034421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact stoichiometry not defined in this finding\", \"Structural basis of coupling not resolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified an N-terminal ER-targeting motif (residues 14-63) that explains why ClC-4 is retained in the ER, establishing a trafficking determinant.\",\n      \"evidence\": \"Heterologous expression, subcellular fractionation of endogenous protein, and N-terminal truncation/chimera constructs\",\n      \"pmids\": [\"17023393\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the motif is overridden for endosomal delivery not yet known\", \"Partner mediating exit not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Provided genetic proof that ClC-4 is required for endosomal acidification driving iron release from transferrin, with specificity for recycling endosomes.\",\n      \"evidence\": \"Clcn4 knockout mouse fibroblasts with endosomal pH, transferrin uptake, EGFR trafficking assays, and iron-chelator rescue\",\n      \"pmids\": [\"19339555\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address neuronal phenotypes\", \"Trafficking route to endosomes not mechanistically explained\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved the trafficking determinant question by showing ClC-4 is monomeric and depends on heterodimerization with ClC-3 to escape the ER and reach endosomal compartments.\",\n      \"evidence\": \"Heterologous co-expression, native gel electrophoresis, and Clcn3 knockout astrocytes\",\n      \"pmids\": [\"28972156\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural interface of the heterodimer not defined\", \"Relative in vivo abundance of homo- vs heterodimers unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Systematically classified disease variants into mechanistic categories, distinguishing loss-of-function from toxic gain-of-function, framing genotype-mechanism relationships for CLCN4 disease.\",\n      \"evidence\": \"Two-electrode voltage-clamp of 59 missense variants in Xenopus oocytes; complementary characterization of additional variants in mammalian cells\",\n      \"pmids\": [\"36385166\", \"35721313\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequences of each class not directly tested\", \"Link to specific clinical severity incompletely mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified TMEM9B as the first accessory subunit regulator of ClC-4 that directly binds and suppresses its transport activity.\",\n      \"evidence\": \"Two-electrode and whole-cell patch-clamp with FLIM-FRET interaction measurement in oocytes and HEK cells\",\n      \"pmids\": [\"39202776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context of TMEM9B regulation in vivo unknown\", \"Mechanism of activity suppression not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrated that CLCN4 variants can act dominant-negatively by suppressing wild-type ClC-3 within heterodimers, explaining dominant disease inheritance.\",\n      \"evidence\": \"Voltage-clamp reconstitution of co-expressed ClC-3/ClC-4 via bicistronic constructs in oocytes and mammalian cells\",\n      \"pmids\": [\"41439993\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Endogenous-level dominant effect not confirmed in patient cells\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Began connecting CLCN4 dysfunction to neuronal-level phenotypes, linking variants to excitatory neuron loss, autophagic disruption, and altered network activity.\",\n      \"evidence\": \"Brain organoids and hiPSC-derived neurons with transcriptomics, autophagy assays, MEG3 rescue, and microelectrode array recordings (both preprints)\",\n      \"pmids\": [\"bio_10.1101_2025.07.16.665078\", \"bio_10.1101_2024.08.29.610281\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Preprints without independent replication\", \"Mechanistic link from ion transport to MEG3/autophagy not established\", \"Direction of expression change (loss vs gain) varies between models\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How endosomal Cl-/H+ exchange by ClC-4 is mechanistically translated into the cell-death, autophagy, and network-activity defects underlying neurodevelopmental disease remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of the ClC-3/ClC-4 heterodimer\", \"Causal chain from ion homeostasis to neuronal phenotype unestablished\", \"In vivo role of TMEM9B regulation unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 9]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005254\", \"supporting_discovery_ids\": [1, 3, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [2, 5, 9, 10]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [7, 10]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 9]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 9]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [6, 9]}\n    ],\n    \"complexes\": [\"ClC-3/ClC-4 heterodimer\"],\n    \"partners\": [\"CLCN3\", \"CLCN5\", \"ATP7B\", \"TMEM9B\", \"CFTR\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}